{
  "id": 19750148,
  "title": "Globus Medical director James R. Tobin sells $3.13 million in shares",
  "url": "https://urgent.news/2026/11/13/globus-medical-director-james-r-tobin-sells-3-13-million-in-shares",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-13T03:16:01.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/globus-medical-director-james-r-tobin-sells-313-million-in-shares-93CH-5024019"
  },
  "original_language": "en",
  "account": null,
  "summary": "James R. Tobin, a director at Globus Medical, sold 41,666 shares of the company's Class A Common Stock on November 10, 2026, for a total of $3,131,547. The sales occurred at prices ranging from $74.58 to $76.05 per share, with two distinct sets of transactions. Additionally, Tobin acquired 41,666 shares through the exercise of stock options for $2,345,782, which were acquired at prices ranging from $43.58 to $65.05 per share. Following these transactions, Tobin directly holds zero shares of Class A Common Stock. Globus Medical reported third-quarter 2026 earnings with non-GAAP earnings per share of $1.23, surpassing expectations of $1.20, but revenue fell short of analysts' estimates, leading to a downgrade of the stock rating by BMO Capital and a neutral rating from BTIG.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}